BCQ-071-111722-57

Live Q&A: Real-world Tactics

to Address Health Inequities
in Melanoma Care
SYLLABUS & COURSE GUIDE
A Free, 30-Minute Live Activity
Premier Date: Thursday, November 17, 2022
6:30 PM - 7:00 PM ET

Login:
www.cmeoutfitters.com/bcq071

Faculty:
Edith Peterson Mitchell, MD, MACP, FCPP, FRCP (Moderator)
Susan C. Taylor, MD, FAAD

Take advantage of our LIVE Q&A segment

during this webcast!
Please click on the Ask Question tab and type your question.
Email your question or comment: questions@cmeoutfitters.com
All other questions: Call CME Outfitters at 877.CME.PROS

This continuing education activity is provided by CME Outfitters.

Live Q&A: Real-world Tactics to Address Health Inequities in Melanoma Care

Information for Participants

Statement of Need
Where the predominance of melanoma is seen in White people, roughly 20 times that of Black people, the weight of later stage
presentation, delayed treatment, and poorer outcomes falls on those of racial and ethnic underserved populations. A culmination of
biases, disparities, and inequities continues a cycle of inadequate oncology treatment for melanoma, thus resulting in delayed diagnosis
and suboptimal clinical management, prognosis, and survival rate.

This live Q&A session is your opportunity to ask questions based on the CME Outfitters BriefCase that focused on racial and ethnic
disparities and health inequities in melanoma. To view the full activity ahead of this live Q&A, click here.

Learning Objectives
At the end of this CME/CE activity, participants should be able to:
• Recognize the impact of health inequities on patients with melanoma when crafting individual treatment strategies for optimal
outcomes.

Financial Support
Supported by an educational grant from the Johnson & Johnson Institute and the Johnson & Johnson Family of Companies.

Target Audience
Physicians, PAs, nurse practitioners, nurses/nurse navigators, pharmacists, and dietitians specializing in oncology, pathology,
radiology, dermatology, and primary care.
Live Q&A: Real-world Tactics to Address Health Inequities in Melanoma Care

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation
Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education
(ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the
healthcare team.

Physicians (ACCME):
CME Outfitters, LLC, designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only
the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC):
This activity is designated for 0.5 contact hours.
Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of
Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)™ from Jointly Accredited Organizations. Nurse
practitioners can also apply for credit through their state boards.
California Residents: This continuing nursing education activity was approved by the California Board of Registered Nursing. CME
Outfitters LLC’s provider number is CEP15510.

Pharmacists (ACPE):
This application-based activity is approved for 0.5 contact hours (0.05 CEUs) of continuing pharmacy credit
(JA0007185-0000-22-133-L01-P).

PAs (AAPA):
CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category
1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5
AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their
participation.

Dietetics (CDR):
Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = Once CPEU). If the activity is
dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed with are commensurate with participation in contact hours
(One 60 minute hour = 1 CPEU). RDs and DTRs are to select activity type 102 in their Activity Log. Performance indicator selection is
at the learner’s discretion.
Live Q&A: Real-world Tactics to Address Health Inequities in Melanoma Care

Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE
activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be
mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified,
and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based
data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not
assumed that these relationships will have a negative impact on the presentations.

Dr. Mitchell reports the following financial relationships:

Advisory Board: Corvus Pharmaceuticals, Inc.

Consultant: Amgen Inc.; Astellas Pharma Inc.; Bristol Myers Squibb; Genentech, Inc.; and SEMA4 OpCo, Inc.

Dr. Taylor reports the following financial relationships:

Advisory Board: AbbVie Inc.; Beiersdorf; Biorez; Galderma Laboratories, L.P.; GloGetter; Hugel America, Inc.; Janssen
Pharmaceuticals, Inc.; L'Oreal USA; Medscape; Scientis SA; and UCB, Inc.

Consultant: Arcutis Biotherapeutics; Armis Biopharma; Beiersdorf; Cara Therapeutics; EPI Health; Evolus, Inc.; Johnson & Johnson;
Piction Health; and Vichy Laboratories

Grants: Pfizer Inc.

Research Support: Concert Pharmaceuticals; Croma-Pharma GmbH; and Eli Lilly and Company

Speakers Bureau: Beiersdorf; Evolus, Inc.; L'Oreal USA; Medscape; and MJH Life Sciences

Stock Shareholder (stock options): Armis Biopharma; GloGetter; and Piction Health

Other Financial or Material Support: McGraw Hill (book royalties) and Mercer Strategies (Board of Directors)

The following peer reviewer and CME Outfitters staff have no financial relationships:

Michael Franks, APRN, AGACNP-BC, FNP-BC (peer reviewer)

Meghann Taft-Lockard (planning committee)
David Modrak, PhD (planning committee)
Sandra Caballero, PharmD (planning committee)
Susan H. Yarbrough, CHCP (planning committee)
Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty
have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses
not approved by the FDA) of products or devices.

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and
participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers
except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-
and-confidentiality-policy.
Live Q&A: Real-world Tactics to Address Health Inequities in Melanoma Care

Faculty Bios

EDITH PETERSON MITCHELL, MD, MACP, FCPP, FRCP (MODERATOR)

Clinical Professor of Medicine and Medical Oncology
Department of Medical Oncology
Director, Center to Eliminate Cancer Disparities
Associate Director, Diversity Affairs
Sidney Kimmel Cancer Center at Jefferson
Philadelphia, PA
116th President of the National Medical Association

Edith Peterson Mitchell, MD, MACP, FCPP, FRCP, is board certified in Internal Medicine and Medical Oncology and is Clinical
Professor of Medicine and Medical Oncology at Sidney Kimmel Medical College at Thomas Jefferson University and Associate Director
for Diversity Programs and Director of the Center to Eliminate Cancer Disparities for Sidney Kimmel Cancer Center at Jefferson.

Dr. Mitchell has spent her medical career helping individuals in medically underserved areas and has demonstrated the importance of
community service and outreach, especially to underserved populations. Her research in breast, colorectal, and pancreatic cancers and
other GI malignancies involves new drug evaluation and chemotherapy, development of new therapeutic regimens, chemoradiation
strategies for combined-modality therapy, patient selection criteria, and supportive care for patients with gastrointestinal cancer.

Dr. Mitchell served as the 116th President of the National Medical Association, and is a member of the American Medical Association,
National Medical Association, Aerospace Medical Association, Association of Military Surgeons, Medical Society of Eastern
Pennsylvania, ECOG/ACRIN Cancer Research Group, and Radiation Therapy Oncology Group. Because of her experience in the
cancer research community, Dr. Mitchell served as a member of the National Cancer Institute Blue Ribbon Panel convened to advise
the National Cancer Advisory Board on then Vice President Biden's National Cancer Moonshot Initiative. In 2019, Dr. Mitchell began
service as a member of the President's Cancer Panel. In 2020, she became a Fellow of the Royal College of Physicians.

In addition to her medical achievements, Dr. Mitchell is a retired United States Air Force Brigadier General.

SUSAN C. TAYLOR, MD, FAAD

Bernett L. Johnson Endowed Professor of Dermatology
Vice Chair for Diversity, Equity and Inclusion Department of Dermatology
Perelman School of Medicine University of Pennsylvania
Founder of the Skin of Color Society
Philadelphia, PA

Susan C. Taylor, MD, FAAD, is a Harvard, Columbia, and University of Pennsylvania educated physician and is the Bernett L. Johnson
Jr. Endowed Professor of Dermatology at the University of Pennsylvania's Perelman School of Medicine in Philadelphia. Dr. Taylor has
performed pioneering work establishing Skin of Color as a sub-specialty within Dermatology. Her work has focused on advancing
clinical knowledge and addressing gaps in research and education regarding skin of color populations. She has led education, policy,
and research initiatives that have invigorated a national dialogue about diversity, health disparities, and skin of color related issues.

Dr. Taylor's clinical focus encompasses disorders that uniquely or disproportionately affect patients of color including alopecia and
pigmentary disorders, cosmetic and appearance enhancing devices, and cultural competency. She serves as Principal Investigator for
Phase II through Phase IV clinical research trials. Dr. Taylor has over 75 original publications and has co-edited two major dermatology
textbooks.

Dr. Taylor is the Past Vice President of the American Academy of Dermatology, founder of the Skin of Color Society, and a Board
Member of the Women's Dermatology Society.